Skip to the main content

Original scientific paper

https://doi.org/10.5562/cca1939

Synthesis, Cytotoxicity Assessment, and Molecular Docking of 4-Substituted-2-p-tolylthiazole Derivatives as Probable c-Src and erb Tyrosine Kinase Inhibitors

Alireza Aliabadi ; Department of Medicinal Chemistry, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran; Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Science
Alireza Foroumadi ; Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran 14174, Iran
Maliheh Safavi ; Institute of Biochemistry and Biophysics, Department of Biochemistry, University of Tehran, Tehran, Iran
Sussan K. Ardestani ; Institute of Biochemistry and Biophysics, Department of Biochemistry, University of Tehran, Tehran, Iran


Full text: english pdf 1.711 Kb

page 245-251

downloads: 1.303

cite


Abstract

In the current project we focused on the synthesis of 4-Substituted-2-p-tolylthiazole derivatives. Cytotoxicity of synthesized compounds were evaluated against T47D breast cancer cell line and also all of the final compounds 3−7 were docked into the active site of c-Src and erb tyrosine kinases. Compound 4 was the most potent derivative in cytotoxicity assay (IC50 = 2.5 µg/mL) and it was also the most potent inhibitor of erb tyrosine kinase (Binding free energy: −10.18 kcal/mol).(doi: 10.5562/cca1939)

Keywords

synthesis; phenylthiazole; cytotoxicity; breast cancer; tyrosine kinase; docking

Hrčak ID:

111219

URI

https://hrcak.srce.hr/111219

Publication date:

20.11.2013.

Visits: 1.989 *